BIOCON Q2 FY27 results at a glance
BIOCON LIMITED. Q2 FY27 key results metrics| Quarter | Q2 FY27 |
|---|
| Quarter ended | 30 Sept 2026 |
|---|
| Revenue | ₹4,389 cr |
|---|
| Revenue YoY | +3.0% |
|---|
| Operating profit | ₹267 cr |
|---|
| Operating margin | 6.1% |
|---|
| Net profit | ₹56.7 cr |
|---|
| Net profit YoY | -32.9% |
|---|
| Net profit QoQ | -59.8% |
|---|
| Net margin | 1.3% |
|---|
| Basic EPS | ₹0.25 |
|---|
| TTM revenue | ₹17,338 cr |
|---|
| TTM net profit | ₹468 cr |
|---|
| TTM net margin | 2.7% |
|---|
BIOCON Q2 FY27 results: what the numbers say
BIOCON LIMITED. (BIOCON) has reported its Q2 FY27 results for the quarter ended 2026-09-30. The company posted revenue of ₹4,389 cr and a net profit of ₹56.7 cr, translating into earnings per share of ₹0.25.
Compared with the same quarter a year earlier, revenue grew marginally by +3.0% and net profit declined strongly by -32.9%. Profit trailing revenue growth suggests costs, interest or tax absorbed part of the topline gain.
Operating profit for the quarter stood at ₹267 cr, an operating margin of 6.1% versus 8.5% a year ago — a contraction of 2.4 percentage points.
BIOCON quarter-wise results table
Revenue
₹4,389 cr
+3.0% YoY
Net profit
₹56.7 cr
-32.9% YoY
Operating profit
₹267 cr
-26.3% YoY
Swipe sideways to see all columns →
BIOCON LIMITED. (BIOCON) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q2 FY272026-09-30 | ₹4,389 cr | ₹267 cr | ₹56.7 cr | 6.1% | 1.3% | ₹0.25 | -32.9% | -59.8% |
| Q1 FY272026-06-30 | ₹4,292 cr | ₹300 cr | ₹141 cr | 7.0% | 3.3% | ₹0.87 | +349.4% | +12.1% |
| Q4 FY262026-03-31 | ₹4,484 cr | ₹507 cr | ₹126 cr | 11.3% | 2.8% | ₹0.79 | — | -12.4% |
| Q3 FY262025-12-31 | ₹4,173 cr | ₹318 cr | ₹144 cr | 7.6% | 3.4% | ₹1.08 | — | +70.2% |
| Q2 FY262025-09-30 | ₹4,263 cr | ₹362 cr | ₹84.5 cr | 8.5% | 2.0% | ₹0.66 | — | +169.1% |
| Q1 FY262025-06-30 | ₹3,910 cr | ₹311 cr | ₹31.4 cr | 8.0% | 0.8% | ₹0.26 | — | — |
| TTM (last 4 quarters) | ₹17,338 cr | ₹1,392 cr | ₹468 cr | 8.0% | 2.7% | ₹2.99 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
BIOCON quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
BIOCON LIMITED. quarterly income statement| Particulars | Q2 FY272026-09-30 | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹4,389 cr | ₹4,292 cr | ₹4,484 cr | ₹4,173 cr | ₹4,263 cr | ₹3,910 cr |
|---|
| Total expenses | ₹4,362 cr | ₹3,992 cr | ₹3,977 cr | ₹3,855 cr | ₹3,900 cr | ₹3,599 cr |
|---|
| Gross profit | — | ₹2,824 cr | — | — | — | — |
|---|
| Operating profit (EBIT) | ₹267 cr | ₹300 cr | ₹507 cr | ₹318 cr | ₹362 cr | ₹311 cr |
|---|
| Operating margin | 6.1% | 7.0% | 11.3% | 7.6% | 8.5% | 8.0% |
|---|
| Interest cost | ₹240 cr | ₹213 cr | ₹232 cr | ₹210 cr | ₹272 cr | ₹277 cr |
|---|
| Profit before tax | ₹54.8 cr | ₹128 cr | ₹248 cr | -₹67.8 cr | ₹171 cr | ₹96.9 cr |
|---|
| Tax expense | -₹1.9 cr | -₹9.2 cr | ₹48.9 cr | -₹16 cr | ₹38.5 cr | ₹7.7 cr |
|---|
| Effective tax rate | -3.5% | -7.2% | 19.8% | 23.6% | 22.5% | 7.9% |
|---|
| Net profit (PAT) | ₹56.7 cr | ₹141 cr | ₹126 cr | ₹144 cr | ₹84.5 cr | ₹31.4 cr |
|---|
| Net profit margin | 1.3% | 3.3% | 2.8% | 3.4% | 2.0% | 0.8% |
|---|
| Basic EPS | ₹0.25 | ₹0.87 | ₹0.79 | ₹1.08 | ₹0.66 | ₹0.26 |
|---|
| Diluted EPS | — | ₹0.87 | ₹0.79 | ₹1.07 | ₹0.65 | ₹0.26 |
|---|
BIOCON results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q2 FY27 | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +3.0% | +9.8% | — | — | — | — |
|---|
| Revenue QoQ | +2.3% | -4.3% | +7.5% | -2.1% | +9.0% | — |
|---|
| Operating profit YoY | -26.3% | -3.6% | — | — | — | — |
|---|
| Operating profit QoQ | -10.9% | -40.9% | +59.3% | -12.2% | +16.5% | — |
|---|
| Net profit YoY | -32.9% | +349.4% | — | — | — | — |
|---|
| Net profit QoQ | -59.8% | +12.1% | -12.4% | +70.2% | +169.1% | — |
|---|
| EPS YoY | -62.1% | +234.6% | — | — | — | — |
|---|
| EPS QoQ | -71.3% | +10.1% | -26.9% | +63.6% | +153.8% | — |
|---|
BIOCON annual results history
Full-year performance for BIOCON LIMITED., useful for reading each quarter in context.
BIOCON LIMITED. annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹16,780 cr | ₹15,052 cr | ₹14,196 cr | ₹10,934 cr |
|---|
| Total expenses | ₹15,058 cr | ₹13,426 cr | ₹12,761 cr | ₹9,307 cr |
|---|
| Gross profit | ₹11,085 cr | ₹9,854 cr | ₹9,289 cr | ₹7,267 cr |
|---|
| Operating profit (EBIT) | ₹1,722 cr | ₹1,626 cr | ₹1,435 cr | ₹1,627 cr |
|---|
| Operating margin | 10.3% | 10.8% | 10.1% | 14.9% |
|---|
| Interest cost | ₹965 cr | ₹888 cr | ₹974 cr | ₹419 cr |
|---|
| Profit before tax | ₹448 cr | ₹1,887 cr | ₹1,525 cr | ₹897 cr |
|---|
| Tax expense | ₹79.1 cr | ₹457 cr | ₹227 cr | ₹254 cr |
|---|
| Effective tax rate | 17.7% | 24.2% | 14.9% | 28.3% |
|---|
| Net profit (PAT) | ₹386 cr | ₹1,013 cr | ₹1,023 cr | ₹463 cr |
|---|
| Net profit margin | 2.3% | 6.7% | 7.2% | 4.2% |
|---|
| Basic EPS | ₹2.82 | ₹8.46 | ₹8.55 | ₹3.88 |
|---|
| Diluted EPS | ₹2.82 | ₹8.46 | ₹8.54 | ₹3.87 |
|---|
Revenue trend and demand read-through
Topline for Q2 FY27 came in at ₹4,389 cr against ₹4,263 cr in Q2 FY26, and ₹4,292 cr in the preceding Q1 FY27 quarter.
On a sequential basis revenue grew +2.3%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹4,362 cr, or 99.4% of revenue, with operating profit declined -26.3% year on year.
Margins, tax and profitability
Net profit of ₹56.7 cr works out to a net margin of 1.3% compared with 2.0% in the year-ago quarter. Margin pressure of this kind usually reflects higher input costs, pricing competition, or a heavier interest and depreciation load.
Below the operating line, BIOCON LIMITED. reported profit before tax of ₹54.8 cr, a tax charge of -₹1.9 cr (effective rate -3.5%), interest cost of ₹240 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹141 cr in Q1 FY27 to ₹56.7 cr in Q2 FY27, a change of -59.8%.
Trailing twelve months and annual context
Across the trailing four quarters BIOCON LIMITED. has generated revenue of ₹17,338 cr and net profit of ₹468 cr, a trailing net margin of 2.7%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹16,780 cr with net profit of ₹386 cr and EPS of ₹2.82, versus the prior year where revenue grew +11.5% and profit declined -61.9%.
What to watch in the next BIOCON quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A single weak quarter matters less than the direction over three to four consecutive quarters.
BIOCON LIMITED. has intimated the exchange that its board meets on 4 Nov 2026 to approve financial results. The figures shown here update when Yahoo Finance publishes the corresponding statement data, which can lag the filing.
Financial figures here are supplied through Yahoo Finance fundamentals and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
BIOCON results coverage
BIOCON quarterly results FAQs
What were BIOCON LIMITED. (BIOCON) Q2 FY27 results?
In Q2 FY27 (quarter ended 30 Sept 2026), BIOCON LIMITED. reported revenue of ₹4,389 cr and net profit of ₹56.7 cr, a change of -32.9% year on year on +3.0% revenue growth. EPS stood at ₹0.25.
What is BIOCON profit margin in Q2 FY27?
BIOCON LIMITED. posted a net profit margin of 1.3% and an operating margin of 6.1% in Q2 FY27. On a trailing twelve-month basis, revenue is ₹17,338 cr and net profit ₹468 cr.
Did BIOCON results beat the previous quarter?
BIOCON LIMITED. net profit changed -59.8% quarter on quarter, from ₹141 cr in Q1 FY27 to ₹56.7 cr in Q2 FY27.
When are BIOCON LIMITED. (BIOCON) quarterly results?
The board of BIOCON LIMITED. meets on 4 Nov 2026 to consider and approve the financial results, as per the exchange filing.
Where can I see BIOCON latest quarterly results?
Our latest BIOCON results coverage — "Biocon Limited Q2 FY27 Results: Net Profit ₹56.7 cr" — breaks down revenue, profit, margins and management commentary.
What is BIOCON LIMITED. annual revenue and profit?
For FY26, BIOCON LIMITED. reported full-year revenue of ₹16,780 cr and net profit of ₹386 cr, with EPS of ₹2.82.
How many quarterly results has BIOCON declared recently?
Past results dates for BIOCON will be listed here from the exchange calendar.
Results dates: NSE board-meeting calendar. Financial figures: Yahoo Finance fundamentals, not a direct exchange filing feed. Last successful data fetch 5 Nov 2026. Figures can be delayed; results change only when the provider publishes them. For information only, not investment advice.
